Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Florida sues Merck over Vioxx costs

Executive Summary

The Attorney General of Florida filed suit against Merck, claiming the company misrepresented and suppressed evidence about the risks of Vioxx (rofecoxib) and as a result its agencies suffered damages from purchasing the drug. The suit notes that the Florida Medicaid Program alone purchased at least $80 million of the pain reliever. An appeals court recently ruled that shareholders could pursue a securities class action alleging Merck defrauded investors by failing to disclose problems with Vioxx (1"The Pink Sheet," Sept. 15, 2008, p. 17)

Related Content

UsernamePublicRestriction

Register

PS050176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel